Literature DB >> 10396373

Hyperprolactinaemia as a reversible cause of weight gain in male patients?

E Delgrange, J Donckier, D Maiter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10396373     DOI： 10.1046/j.1365-2265.1999.00700.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  7 in total

1.  Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.

Authors:  Arijit Chattopadhyay; Anil Bhansali; Shariq R Masoodi
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Prolactinoma-associated obesity treated with bupropion and methylphenidate.

Authors:  Jan Terock; Fritz Hohagen; Dirk Petersen; Bartosz Zurowski
Journal:  Ther Adv Psychopharmacol       Date:  2013-06

3.  Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

Authors:  Katarina Berinder; Thomas Nyström; Charlotte Höybye; Kerstin Hall; Anna-Lena Hulting
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

4.  Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma.

Authors:  Serap Soytac Inancli; Alper Usluogullari; Yusuf Ustu; Sedat Caner; Abbas Ali Tam; Reyhan Ersoy; Bekir Cakir
Journal:  Endocrine       Date:  2012-12-12       Impact factor: 3.633

Review 5.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists.

Authors:  Flávia Regina Pinho Barbosa; Cintia Marques dos Santos Silva; Giovanna Aparecida Balarini Lima; Giovanna Aparecida Balarinni Lima; Leila Warszawski; Romeu Cortes Domingues; Michele Dominic; Rosita Fontes; Leonardo Vieira Neto; Mônica Roberto Gadelha
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

Review 7.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.